Gå direkt till innehåll

Kategorier: barn

  • Unimedic Pharma AB out-license Melatonin oral solution in Belgium to TwinPharma BV

    Unimedic Pharma AB has signed a distribution agreement with TwinPharma BV for the launch of Melatonin 1 mg/ml oral solution in Belgium.
    Unimedic Pharma and TwinPharma entered into a supply and distribution agreement in 2017 and the addition of Melatonin 1mg/ml is the third product in the collaboration.
    In this partnership, TwinPharma is appointed exclusive distributor of Melatonin Unimedi

  • Unimedic Pharma AB enter a collaboration with Consilient Health Limited for the launch of Melatonin oral solution in the UK

    Unimedic Pharma AB have signed a license and supply agreement with Consilient Health for the launch of Melatonin 1 mg/ml oral solution in the UK. On November 16, 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) granted Melatonin Consilient Health approval for insomnia in children with ADHD, as well as for short-term jet-lag therapy in adults

  • Unimedic Pharma AB lanserar en fungerande behandling mot mollusker

    Unimedic Pharma AB lanserar nu NoPoxivir®, det enda medlet mot mollusker. Väl tolererat, effektivt och med kliniskt bevisad snabb effekt. NoPoxivir® är den enda produkten i Norden som har en indikation mot mollusker och detta är unikt. NoPoxivir finns nu receptfritt på samtliga apotekskedjor.